Dr. Reddy’s Laboratories Announces U.S. FDA Completes Inspection at Srikakulam Unit, Issues Form 483
https://www.bseindia.com/xml-data/corpfiling/AttachLive/2b7475c2-d2d2-48e9-8f62-88ec9f147b6c.pdf
The U.S. drug safety agency finished checking one of Dr. Reddy's factories and found some things to fix (Form 483 means notes about improvements needed). This is a normal step in making sure medicines are safe, and the company now knows what to work on.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.